Advwm.com

Advwm.com has Server used 54.164.9.107 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2016-07-27 (5 years, 60 days) and hosted in Ashburn United States, server ping response time 11 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Advwm keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Advwnture land
2 Advem
3 Advems.com
4 Advem02n0np8ag
5 Advem04n0np8ag
6 Advemtire amd
7 Advemt jea tj
8 Advemar laredo texas
9 Advemar forwarding laredo tx

Hosting Provider

Website: Advwm.com
Hostname: ec2-54-164-9-107.compute-1.amazonaws.com
Country:
Region: VA
City: Ashburn
Postal Code: 20147
Latitude: 39.018001556396
Longitude: -77.539001464844
Area Code: 703
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (52 min ago)

   » Bobbyjonesband.com (1 day ago)

   » Huishoubao.com (5 hours ago)

   » M1file.com (1 day ago)

   » Renhomesantalya.com (13 day ago)

   » Napadrivertours.com (1 day ago)

Results For Websites Listing

Found 48 Websites with content related to this domain, It is result after search with search engine

Advantage Wealth Management

Advwm.com   DA: 13 PA: 13 MOZ Rank: 26

  • Whether you’re facing retirement—or looking to better understand certain investment ideas—we can help you address your most pressing money questions
  • Our first priority is your overall financial success
  • We want to learn more about your personal situation, identify your dreams and goals, and understand your tolerance for risk.

Adverum Biotechnologies

Adverum.com   DA: 11 PA: 11 MOZ Rank: 23

  • Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulatory Affairs
  • Adverum Reports Second Quarter 2021 Results
  • Adverum Provides Update on ADVM-022 and the INFINITY Trial in …

Adverum Biotechnologies, Inc. (ADVM) Stock Price, News

Finance.yahoo.com   DA: 17 PA: 12 MOZ Rank: 31

Find the latest Adverum Biotechnologies, Inc. (ADVM) stock quote, history, news and other vital information to help you with your stock trading and investing.

Pipeline Adverum Biotechnologies

Adverum.com   DA: 11 PA: 10 MOZ Rank: 24

  • In recognition of the need for new treatment options for wet AMD, the U.S
  • Food and Drug Administration (FDA) granted Fast Track designation to ADVM-022 for the treatment of wet AMD
  • OPTIC Trial of ADVM-022 in Wet AMD
  • The OPTIC trial is designed as a multi-center, open-label, dose-escalation trial evaluating the safety and tolerability of a single intravitreal (IVT

Adverum Biotechnologies, Inc.

Investors.adverum.com   DA: 21 PA: 22 MOZ Rank: 47

  • Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases
  • We develop gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein.

ADVM Adverum Biotechnologies, Inc — Stock Price And

Stocktwits.com   DA: 14 PA: 12 MOZ Rank: 31

  • ADVM Adverum Biotechnologies, Inc — Stock Price and Discussion | Stocktwits
  • Adverum Biotechnologies, Inc NASDAQ Updated Sep 15, 2021 9:41 PM
  • ADVM 2.17 0.00 (0.00%) Post-Market 0.01 (0.46%) 4,912

Advm Investments, LLC In Woodland Hills CA

Corporationwiki.com   DA: 23 PA: 50 MOZ Rank: 79

  • Advm Investments, LLC filed as a Domestic in the State of California on Monday, December 31, 2012 and is approximately nine years old, according to public records filed with California Secretary of State.

עמוד הבית

Advm.org.il   DA: 11 PA: 11 MOZ Rank: 29

  • המכון לייצור מתקדם, מיסודו של מנהל תעשיות במשרד הכלכלה, פועל ליצירת תעשייה ישראלית משגשגת, יעילה וחדשנית, באמצעות יישום תהליכי ייצור מתקדמים
  • מטרתו הינה שיפור הפריון בתעשייה היצרנית בעזרת

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 75

LOS ANGELES, CA / ACCESSWIRE / February 26, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that …

Adverum Biotechnologies

En.wikipedia.org   DA: 16 PA: 29 MOZ Rank: 54

  • Adverum Biotechnologies, formerly known as Avalanche Biotechnologies, is a publicly traded (NASDAQ:ADVM) clinical stage gene therapy company located in Redwood City, California
  • The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD) [5] and diabetic macular

ADVM Stock Price Adverum Biotechnologies Inc. Stock

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 50

  • ADVM | Complete Adverum Biotechnologies Inc
  • View real-time stock prices and stock quotes for a full financial overview.

Adverum Biotechnologies Short Interest Ratio And Volume

Marketbeat.com   DA: 18 PA: 35 MOZ Rank: 64

  • Short selling ADVM is an investing strategy that aims to generate trading profit from Adverum Biotechnologies as its price is falling
  • Adverum Biotechnologies' stock is trading down $0.04 today
  • To short Adverum Biotechnologies stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the

Environmental Data & Consulting ADVM2 Denver, CO

Advm2.com   DA: 9 PA: 9 MOZ Rank: 30

  • Environmental Consulting Solutions
  • Securing your project's future through streamlined permitting
  • Over 25 years field experience working towards getting you the right permit
  • Let ADVM2 customize your Air Monitoring Solution
  • We've installed solutions from …

ADVM: Adverum Biotechnologies Inc

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 37

Get Adverum Biotechnologies Inc (ADVM:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

ADVM Stock Snapshot

Eresearch.fidelity.com   DA: 22 PA: 39 MOZ Rank: 75

  • ( ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Jim Wang, Ph.D., has been appointed senior vice president, head of regulatory affairs

Adverum Biotechnologies Inc (ADVM) Quote

Morningstar.com   DA: 19 PA: 23 MOZ Rank: 57

  • Learn about ADVM (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials
  • Start a 14-day free trial to Morningstar Premium to unlock our

Adverum Biotechnologies, Inc. (ADVM) Stock Price Today

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 44

  • A high-level overview of Adverum Biotechnologies, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Initial Statement Of Beneficial Ownership (3)

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 79

  • Name and Address of Reporting Person * THRIFT JACK ANTHONY: 2
  • Date of Event Requiring Statement (MM/DD/YYYY) 9/2/2021 : 3
  • Issuer Name and Ticker or Trading Symbol Adverum Biotechnologies, Inc
  • [ADVM] (Last) (First) (Middle) C/O ADVERUM BIOTECHNOLOGIES, INC., 800 SAGINAW DRIVE

Adverum Biotechnologies, Inc. Common Stock (ADVM) Stock

Nasdaq.com   DA: 14 PA: 28 MOZ Rank: 60

  • Common Stock (ADVM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

ADVM Insider Buying And Selling (Adverum Biotechnologies)

Marketbeat.com   DA: 18 PA: 35 MOZ Rank: 72

Which Adverum Biotechnologies insiders have been buying company stock? The following insiders have purchased Adverum Biotechnologies stock in the last 24 months: James Paul Scopa ($157,900.00), Laurent Fischer ($197,958.00), Patrick Machado ($115,200.00), and Peter Soparkar ($99,996.00).

Adverum Biotechnologies Stock Quote. ADVM

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 82

Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and …

Adverum Biotechnologies (ADVM) Stock Message Board

Investorshub.advfn.com   DA: 22 PA: 36 MOZ Rank: 79

  • ADVM News: Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulatory Affairs
  • ADVM News: Current Report Filing (8-k) 08/10/2021 10:08:16 PM
  • ADVM News: Adverum Biotechnologies EPS misses by $0.07
  • ADVM News: Quarterly Report (10-q) 08/05/2021 04:24:36 PM.

Should I Buy Adverum Biotechnologies, Inc. (ADVM)

Zacks.com   DA: 13 PA: 40 MOZ Rank: 75

Should I buy Adverum Biotechnologies, Inc. (ADVM)? Use the Zacks Rank and Style Scores to find out is ADVM is right for your portfolio.

Disk Group Compatibility

Docs.oracle.com   DA: 15 PA: 50 MOZ Rank: 88

  • The value for the disk group COMPATIBLE.ADVM attribute determines whether the disk group can contain Oracle ADVM volumes
  • The value must be set to 11.2 or higher
  • Before setting this attribute, the COMPATIBLE.ASM value must be 11.2 or higher
  • Also, the Oracle ADVM volume drivers must be loaded in the supported environment.

Why Adverum Biotechnologies Stock Sank In May The Motley

Fool.com   DA: 12 PA: 50 MOZ Rank: 86

  • Shares of developmental gene therapy company Adverum Biotechnologies ( NASDAQ:ADVM) sank by 11.3% during the month of May, according to data provided by S&P Global Market Intelligence

We Analyzed The Future Direction Of Adverum

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 89

  • ADVM currently public float of 97.33M and currently shorts hold a 12.49% ratio of that float
  • Today, the average trading volume of ADVM was 2.23M shares
  • ADVM stocks went down by -7.23% for the week, with a monthly drop of -21.96% and a quarterly performance of -35.29%, while its annual performance rate touched -83.14%.

Adverum Provides Update On ADVM-022 And The INFINITY Trial

Investors.adverum.com   DA: 21 PA: 50 MOZ Rank: 97

  • Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases
  • Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration.

Oracle ACFS And Oracle ADVM

Docs.oracle.com   DA: 15 PA: 50 MOZ Rank: 92

  • Oracle ACFS and Oracle ADVM Support on Linux x86–64 Oracle ACFS and Oracle ADVM are supported on Oracle Linux, Red Hat Enterprise Linux, and SUSE Linux Enterprise Server
  • Restrictions and Guidelines for Oracle ACFS Review these topics as part of your storage plan for using Oracle ACFS for single instance and cluster configurations.

ADVM Adverum Biotechnologies, Inc. Stock Quote

Finviz.com   DA: 10 PA: 11 MOZ Rank: 49

Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema.

Adverum Biotechnologies, Inc.

Zacks.com   DA: 13 PA: 17 MOZ Rank: 59

  • View Adverum Biotechnologies, Inc
  • ADVM investment & stock information
  • Get the latest Adverum Biotechnologies, Inc
  • ADVM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Adverum Biotechnlgs (ADVM) Recent Earnings

Earningswhispers.com   DA: 24 PA: 16 MOZ Rank: 70

  • Adverum Biotechnlgs (ADVM) Recent Earnings
  • Adverum Biotechnlgs (ADVM) reported a 2nd Quarter June 2021 loss of $0.45 per share on revenue of $0.0 million
  • The consensus estimate was a loss of $0.37 per share on revenue of $0.1 million

Adverum Biotechnologies (ADVM) Moves To Buy: Rationale

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 95

  • Adverum Biotechnologies (ADVM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy)
  • This upgrade is essentially a reflection of an upward trend in

Adverum Biotechnologies Announces Positive Interim Data

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 18

  • Present clinical data from INFINITY in the second half of 2021; Manufacturing
  • Initiating process scale-up from 200L to 1000L scale to …

Adverum Biotechnologies . ADVM Stock Price, News, Charts

Benzinga.com   DA: 16 PA: 11 MOZ Rank: 60

  • The latest price target for Adverum Biotechnologies ( NASDAQ: ADVM) was reported by SVB Leerink on May 3, 2021
  • The analyst firm set a price target for 5.00 expecting ADVM to …

Adverum Biotechnologies Inc. (NASDAQ: ADVM) Stock Forecast

Stocksregister.com   DA: 18 PA: 50 MOZ Rank: 16

  • The trading price of Adverum Biotechnologies Inc
  • (NASDAQ:ADVM) closed higher on Friday, September 17, closing at $2.31, 3.59% higher than its previous close
  • Traders who pay close attention to intraday price movement should know that it fluctuated between $2.18 and $2.42

Adverum Biotechnologies Inc. [ADVM] Revenue Clocked In At

Dbtnews.com   DA: 11 PA: 50 MOZ Rank: 96

  • [NASDAQ: ADVM] price surged by 2.76 percent to reach at $0.06
  • The company report on August 23, 2021 that Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulatory Affairs.
  • (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and …

ADVM Adverum Biotechnologies Inc. Analyst Estimates

Marketwatch.com   DA: 19 PA: 38 MOZ Rank: 93

  • analyst estimates, including ADVM earnings per share estimates and analyst recommendations.

Adverum Biotechnologies Inc (ADVM) AAII Stock Evaluator

Aaii.com   DA: 12 PA: 18 MOZ Rank: 67

  • is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases
  • The Company is evaluating its gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its …

Adverum Biotechnologies (ADVM) Stock Price, Quote & News

Stockanalysis.com   DA: 17 PA: 13 MOZ Rank: 68

  • About ADVM Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases
  • Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related

ADVM-Adverum Biotechnologies, Inc.-基本資料-美股-MoneyDJ理 …

Money.moneydj.com   DA: 17 PA: 24 MOZ Rank: 80

  • Adverum Biotechnologies〈ADVM
  • (AAVL.US)成立於2006年,原名「Avalanche Biotechnologies, Inc.」,2016年5月更為現名,總部位於加州Menlo Park,為一家臨床階段之生物科技公司,主要基於其Ocular BioFactory平台,專注於發現及開發治療眼部疾病之新型基因療法

Safety Dose Finding Study Of ADVM-043 Gene Therapy To

Clinicaltrials.gov   DA: 18 PA: 21 MOZ Rank: 79

  • ADVM-043 is an investigational gene therapy product (serotype AAVrh.10 vector) expressing human A1AT that is intended to deliver a functional gene to the liver of patients with A1AT deficiency
  • Study ADVM-043-01 will study up to 4 dose levels in up to 20 patients and assess the hypothesis that a single administration of an AAV vector expressing

Recently Analyzed Sites

Revo.com (52 min ago)

Bobbyjonesband.com (1 day ago)

Huishoubao.com (5 hours ago)

M1file.com (1 day ago)

Renhomesantalya.com (13 day ago)

Trekksoft.com (1 day ago)

Tibbo.com (4 day ago)

Bosquevilleisd.org (7 seconds ago)

Tailspinbandsc.com (2 day ago)

Dungscanada.com (4 day ago)

Jfsorange.org (2 day ago)

Marloweslu.com (6 day ago)